Dementia with Lewy bodies

Citations 21-30 of 62 total displayed.

Past content (since Oct 2001):

ARTICLES
Cholinesterase inhibitors reduce cortical Aß in dementia with Lewy bodies: C. G. Ballard, K. A. Chalmers, C. Todd, I. G. McKeith, J. T. O’Brien, G. Wilcock, S. Love, and E. K. Perry
Neurology 2007; 68: 1726-1729. [Abstract] [Full text] [PDF]

VIEWS & REVIEWS
DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers: C. F. Lippa, J. E. Duda, M. Grossman, H. I. Hurtig, D. Aarsland, B. F. Boeve, D. J. Brooks, D. W. Dickson, B. Dubois, M. Emre, S. Fahn, J. M. Farmer, D. Galasko, J. E. Galvin, C. G. Goetz, J. H. Growdon, K. A. Gwinn-Hardy, J. Hardy, P. Heutink, T. Iwatsubo, K. Kosaka, V. M.-Y. Lee, J. B. Leverenz, E. Masliah, I. G. McKeith, R. L. Nussbaum, C. W. Olanow, B. M. Ravina, A. B. Singleton, C. M. Tanner, J. Q. Trojanowski, Z. K. Wszolek for the DLB/PDD Working Group
Neurology 2007; 68: 812-819. [Abstract] [Full text] [PDF]

EDITORIALS
Characterizing clinical phenotypes: The Lewys in their life or the life of their Lewys?: Carol F. Lippa and Murat Emre
Neurology 2006; 67: 1910-1911. [Full text] [PDF]

ARTICLES
Differences in neuropathologic characteristics across the Lewy body dementia spectrum: C. Ballard, I. Ziabreva, R. Perry, J. P. Larsen, J. O'Brien, I. McKeith, E. Perry, and D. Aarsland
Neurology 2006; 67: 1931-1934. [Abstract] [Full text] [PDF]

ARTICLES
Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease: Monique M. Williams, Chengjie Xiong, John C. Morris, and James E. Galvin
Neurology 2006; 67: 1935-1941. [Abstract] [Full text] [PDF]

BRIEF COMMUNICATIONS
Glucocerebrosidase mutations are an important risk factor for Lewy body disorders: O. Goker-Alpan, B. I. Giasson, M. J. Eblan, J. Nguyen, H. I. Hurtig, V. M.-Y. Lee, J. Q. Trojanowski, and E. Sidransky
Neurology 2006; 67: 908-910. [Abstract] [Full text] [PDF]

ARTICLES
Lewy bodies in the amygdala increase risk for major depression in subjects with Alzheimer disease: O. L. Lopez, J. T. Becker, R. A. Sweet, F. J. Martin-Sanchez, and R. L. Hamilton
Neurology 2006; 67: 660-665. [Abstract] [Full text] [PDF]

ARTICLES
Value of ¹²³I-MIBG radioactivity in the differential diagnosis of DLB from AD: M. Yoshita, J. Taki, K. Yokoyama, M. Noguchi-Shinohara, Y. Matsumoto, K. Nakajima, and M. Yamada
Neurology 2006; 66: 1850-1854. [Abstract] [Full text] [PDF]

BRIEF COMMUNICATIONS
Family history of dementia is a risk factor for Lewy body disease: B. K. Woodruff, N. R. Graff-Radford, T. J. Ferman, D. W. Dickson, M. W. DeLucia, J. E. Crook, Z. Arvanitakis, S. Brassler, C. Waters, W. Barker, and R. Duara
Neurology 2006; 66: 1949-1950. [Abstract] [Full text] [PDF]

BRIEF COMMUNICATIONS
Selective dendritic degeneration of medium spiny neurons in dementia with Lewy bodies: S. Zaja-Milatovic, C. D. Keene, K. S. Montine, J. B. Leverenz, D. Tsuang, and T. J. Montine
Neurology 2006; 66: 1591-1593. [Abstract] [Full text] [PDF]

Collected Resources Home

HOME